Targeted proteomics methods in their different flavors rely on the use of a few peptides as proxies for protein quantitation, which need to be specified either prior or after data acquisition.
Targeted proteomics has been the method of choice for reproducible protein quantitation in multiple experimental conditions 1 and large sample cohorts 2, 3 as it overcomes the undersampling effects associated to discovery proteomics. Due to its analytical capabilities, targeted proteomics has gained significant popularity in the recent years, and multiple methods have been developed that combine different approaches of targeted acquisition and targeted data analysis. [4] [5] [6] [7] Targeted proteomics methods in their different flavors rely on the use of a few peptides as proxies for protein quantitation, which need to be specified either prior-SRM and PRM-or after-MSX and SWATH-data acquisition. However, in contrast to discovery methods that use all identified peptides for a given protein to estimate its abundance, targeted proteomics methods are limited in the number of peptides that are used for protein quantitation. As only few peptides per protein are acquired or extracted in targeted experiments, the selection of peptides that are used for targeted protein quantitation becomes crucial, and a wrong peptide selection (i.e. a peptide that does not represent the true fold-change of the protein of interest) might lead to a biased protein quantitation.
Some studies have experimentally defined peptides with good quantitative response for certain subsets of proteins, 8 while others have described heuristics to predict the detectability by mass spectrometry of unique peptides based on their physicochemical properties and previous experimental data. 9, 10 Rules have been proposed to guide peptide selection for targeted proteomics studies, which have generally been based on the amino acidic composition of the peptide sequences. The avoidance of peptides prone to chemical reactions such as spontaneous deamidation, uncontrolled oxidation or water loss, 11 or bearing missed cleavages has traditionally been described as highly desirable for targeted protein quantitation. However, often it is difficult to find a peptide that satisfies all the described rules for a given protein, and even if a fully compliant peptide is selected, there is no guarantee that another version of the same peptide is present bearing a missed cleavage, a chemical or a post-translational modification, or a single point mutation, as true complexity of proteomes is generally difficult to predict. Therefore, the current procedure of peptide selection might be of limited use for the community, as the common rules do not imply that not-conform peptides are not reproducibly generated nor they guarantee that the selected peptides correctly represent the behaviour of the protein abundance in different conditions.
To illustrate this situation, in this work we evaluated the impact of non-compliant peptides as surrogates for targeted protein quantitation and revisited the way peptides are selected in targeted proteomics studies. For this purpose we used an already published dataset from our group consisting of a mixture of thirty commercial proteins spiked in an E. coli background. 12 Briefly, five mixes were prepared in triplicate containing different ratios of the spiked-in proteins in the E. coli background, and the samples were subjected either to an in-solution or a filter-aided digestion with trypsin prior shotgun mass spectrometry acquisition. Initially we assessed the frequency, extend and reproducibility of the most common peptide chemical modifications from the E. coli proteome background for both the in-solution and filteraided original datasets (Table 1) . 12 The results obtained from the re-analysis of this MS1 quantitative dataset suggest that the selection of tryptic peptides with potential sites of modifications for targeted proteomics studies have minimal incidence in relative protein quantitation as either these peptides are rarely modified or because when the modification occurs, it generates reproducible peptide areas that should not affect peptide relative quantitation (Table 1 ). Exceptions to these observations might be the spontaneously thermodynamically favoured cyclization of N-terminal glutamine to pyro-glutamate, and in lower proportion asparagine deamidation and methionine oxidation.
However, to further assess the impact of selecting peptides with potential sites of modification in protein quantitation, we used the areas of the different identified peptides to estimate the known ratios of the spiked-in proteins within the original dataset (Table 2) . 12 Noteworthy, only a low percentage of the quantified peptides within the analysed dataset (<10%) fulfilled all the requirements to be classified as fully-compliant peptides according to the commonly used guidelines i.e. without residues prone to cyclize, without residues prone to oxidation (Trp, His, Met), without residues prone to deamidation (Asn, Gln), and without residues that favour the presence of different cis-trans isomers (Pro) ( Table 2) . Nonetheless, peptides bearing potential sites of chemical modification did not exhibit a higher error in the protein fold-change estimation when compared to canonical proteotypic peptides. Similarly, no particular trend that affected protein relative quantitation was observed from peptides containing certain amino acidic residues, thus evidencing that the amino acid composition per se does not determine the quantitative properties of a peptide.
To ensure that the observations described were not dataset dependent, we took the MS1-based quantitation data as reported in another publicly available dataset and analysed the physicochemical properties of the peptides that better represent protein fold-changes between different human cell lines. 13 In most experimental designs, the true protein fold-change between biological samples is unknown. Therefore, we made the assumption that the protein fold-change calculated with all its unique peptides is the one that best represents the true protein fold-change of a given protein. Based on this assumption, we set the comparison HeLa vs. HepG2 cells, and GAMG vs. HEK293 cells, and estimated the protein abundance fold-changes using all available unique peptide areas with the MSstats R package. 14 Then we compared the protein log-fold change estimated with all peptides to the fold-change of each single peptide and ranked the peptides accordingly ( Figure 1A , Table S-1). Thus, for each quantified protein we defined a first peptide that corresponded to the peptide with the lowest difference between the estimated protein fold-change and the peptide fold-change; the last peptide, being the peptide with the highest difference between the calculated fold-changes; and the remaining peptides that were classified as others. Although first and last peptides differed substantially on the assessment of the protein fold-change ( Figure 1B and 1C) , the frequency of peptides bearing potential sites of chemical modification classified as first or last peptide were almost the same (Figure 1D and   1E ).
These observations show that aminoacid-based rules to select peptides for targeted studies such as SRM, PRM, MSX and SWATH do not guarantee good quantitative behaviour of the selected peptides, and that selection based on the avoidance of potential sites of modifications might be close to random peptide selection in terms of protein fold-change estimation. Indeed, several previous works had successfully used peptides with missed cleavages or containing several potential sites of chemical modification for targeted proteomics analyses, as these peptides were shown to be reproducibly generated from replicate samples. [15] [16] [17] Therefore, given these evidences it seems advisable to not rely on the aminoacidic composition of a peptide but rather on experimental data-i.e. pilot shotgun or data-independent experiments with the system under study-to assess the quantitative behaviour of the peptides to be targeted, and thus select peptides that correctly represent true protein fold-changes in targeted proteomics studies. The frequency, extend and reproducibility of peptide chemical modifications were calculated from the identified peptides of the E. coli background proteome in the three replicates of mix 3 from the original dataset. 12 The frequency of a modification was calculated as the number of peptides bearing a particular modification in respect to the total number of peptides containing the potentially modifiable residue (% peptides). In the case of peptides identified as both modified and unmodified, the extent of the modification was calculated as the relative area of the modified peptide form versus the sum of areas of the modified and unmodified peptide forms. Due to possible differences in the response factor between the modified and unmodified peptide versions, the calculated proportions are just an estimation of their relative abundances.
Finally, the modification reproducibility among replicates was calculated based on the standard deviation of the extent of the modification among the three replicates of mix 3 from the original dataset. 12 *Only peptides that contained Q but not N were considered.
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Average error on protein ratio estimation and average peptide log2(area) according to peptide amino acid composition.
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The areas of the different identified peptides were used to estimate the known ratios of the spiked-in proteins between mixes 3, 4 and 5 of the original dataset. 12 The error on the protein fold-change estimation was calculated for each spiked-in protein using the difference between the known protein fold-change and the fold-change estimated by each peptide, with the formula |log2(fold-change peptide) -log2(fold-change protein)| / |log2(fold-change protein)|. Table S-1 List of unique peptides per protein classified as "first", "other" and "last" according how close the peptide fold-change is to the estimated protein fold change. Protein and peptide fold changes have been calculated with the MSstats R package from the peptide areas reported in the original manuscript (Geiger et al. Mol Cell Proteomics 11, M111.014050; PMID:22278370).
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